Developing a systematic approach to safer medication use during pregnancy: Summary of a Centers for Disease Control and Prevention-convened meeting

American Journal of Obstetrics and Gynecology

Volumn 211, Issue 3, 2014, Pages

  Broussard, Cheryl S ^a   Frey, Meghan T ^a,b   Hernandez Diaz, Sonia ^c   Greene, Michael F ^d   Chambers, Christina D ^e   Sahin, Leyla ^f   Collins Sharp, Beth A ^g   Honein, Margaret A ^a  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b OAK RIDGE INSTITUTE FOR SCIENCE AND EDUCATION   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Center for Drug Evaluation and Research   (United States)

^g AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTERS FOR DISEASE CONTROL AND PREVENTION; EXPERT REVIEW; MEDICATIONS; PREGNANCY; TERATOGENS;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); FEMALE; FETUS; HUMANS; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS; SAFETY; UNITED STATES;

EID: 84907972250     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2014.05.040     Document Type: Conference Paper

References (37)